Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K060822
    Date Cleared
    2006-05-23

    (57 days)

    Product Code
    Regulation Number
    886.1570
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K942104

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Keeler Vamage Plus Indirect Ophthalmoscope is intended to examine the Cornea, aqueous, lens, vitreous and retina of the eye.

    Device Description

    The Vantage Plus is a head mounted Binocular Indirect ophthalmoscope designed to be used by trained personnel for illuminating and viewing parts of the eye such as the Cornea and retina when used in conjunction with an ophthalmic lens. The instrument has two main elements i) The illumination element ii) the viewing element. The illumination element consists of a 6Volt, 5Watt Xenon filament lamp, a condensing lens, IR filtration, User filters for diagnostic purposes, variable stop sizes for increasing/decreasing light aperture sizes, a projection lens and an illumination mirror used by the user to direct the light. The binocular Viewing element consists of low powered Viewing Lenses (+2 dioptre) and directional mirrors which are adjustable to obtain optimal views of the eye. The unit has adjustable illumination levels and is powered by the same power sources to that used on the Vantage (Re: 510(k) K942104).

    To improve the ease of use of the instrument, the Vantage Plus combines the Aperture selector control and the Viewing mirror adjustments to achieve optimal instrument setting with minimum fuss. This feature is not present on the Vantage (Re: 510(k) K942104).

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the Keeler Vantage Plus Binocular Indirect Ophthalmoscope, structured according to your requested information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The submission primarily focuses on demonstrating substantial equivalence to a predicate device (Vantage Binocular Indirect Ophthalmoscope) rather than presenting a study with specific acceptance criteria that the device meets to establish a new performance benchmark. Instead, it compares the technological characteristics and safety features of the new device against the predicate.

    Here's a table based on the provided "Comparison of Indirect Ophthalmoscope Technological Characteristics," where the "Acceptance Criteria" are implied by the predicate device's characteristics and the new device's performance aligns with or is considered equivalent to those.

    CriteriaAcceptance Criteria (Implied by Predicate)Reported Device Performance (Vantage Plus)
    TypeBinocular (Headband Mounted)Binocular (Headband Mounted)
    Illumination6V, 10 Watt Halogen Filament Bulb (Predicate)6V, 5 Watt Xenon Filament Bulb (Different bulb type, but considered equivalent/improved for intended use)
    Safety Filter IR BlockerSelectablePermanent (Considered an improvement for safety)
    Light Output (60mm patch size)954 Lux (Average from selection of bulbs)913 Lux (Comparable and within an acceptable range for ophthalmoscopic examination)
    Blue FilterSelectableSelectable
    Red Free FilterSelectableSelectable
    DiffuserSelectableSelectable
    Light aperture sizesLarge (60mm), Medium (45mm), Small (22mm)Large (60mm) +/-5%, Medium (45mm) +/-5%, Small (22mm) +/-5% (Within acceptable tolerance of predicate)
    Inter Pupillary Distance Adj.52mm to 76mm52mm to 76mm (No change from predicate)
    Lens Power Viewing Optics+2 Dioptre+2 Dioptre
    AttachmentsHi-Mag, Teaching MirrorHi-Mag, Teaching Mirror
    Power SourcesWall Pack, Smart Pack, Wireless battery Pack (Compliant with BS EN 60601-1 and 60601-1-2)Wall Pack, Smart Pack, Wireless Battery Pack (Same as predicate, and stated to be compliant with BS EN 60601-1 and 60601-1-2 with no adverse reports for these products)
    Quality ApprovalsISO 9001:2000 and BS EN 13485:2003 compliant; full risk analysis, risk management, design verification/validation conducted to meet/surpass product specifications and relevant standards.Keeler is an ISO 9001:2000 and BS EN 13485:2003 compliant company, follows the stated design process including risk analysis and validation to meet/surpass specifications and comply with relevant standards.
    Risk ManagementCompleted as per BS EN ISO 14971:2001Completed as per BS EN ISO 14971:2001
    Light HazardWithin limits specified for Optical radiation Hazard (Section 6.3) of BS EN ISO 15004:1998Tested in accordance with BS EN ISO 15004:1998 and within specified limits (See separate report under Technical Documentation).
    Electrical SafetyPower sources compliant with BS EN 60601-1 and 60601-1-2 with no adverse reports.Power sources are the same as the predicate, compliant with BS EN 60601-1 and 60601-1-2, and Keeler has not received any adverse reports on these products.
    Explosion HazardLow probability; measures taken using non-explosive materials, meeting electrical safety requirements, detailed user instructions.Low probability; measures taken using non-explosive materials, meeting electrical safety requirements, detailed user instructions.
    Fire HazardLow probability; self-extinguishing materials (HB or VO rated), materials in vicinity of illumination (5W Xenon lamp) designed for high-temperature environments.Low probability; self-extinguishing materials (HB or VO rated), materials in vicinity of illumination (5W Xenon lamp) designed for high-temperature environments.
    Surface TemperatureCompliance with BS EN ISO 60601-1 for temperature of external surfaces and controls; caution instruction "Do not remove bulb whilst hot."Complies with BS EN ISO 60601-1 for temperature of external surfaces and controls; caution instruction "Do not remove bulb whilst hot."

    2. Sample Size Used for the Test Set and the Data Provenance

    The document does not describe a clinical "test set" in the traditional sense for evaluating diagnostic accuracy or a specific performance metric against a ground truth. Instead, the submission details a technical comparison and safety assessment against a predicate device.

    • Test Set/Sample Size: Not explicitly applicable in the context of a clinical performance study. The "measurements" for characteristics like light output and aperture sizes were taken from a "selection of bulbs" and from "440mm from the front of the instrument" on "a fully functional prototype." Specific numbers for how many prototypes were tested for these physical characteristics are not provided.
    • Data Provenance: The testing appears to have been conducted internally by Keeler Ltd., located in Windsor, Berkshire, United Kingdom. The data is retrospective in the sense that it's a comparison to an already marketed device, but the testing on the "Vantage Plus" prototype would be prospective for the new device.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

    This information is not provided because the submission does not involve a clinical study requiring expert-established ground truth for a diagnostic outcome. The "ground truth" for the technical characteristics is established by the measurements and adherence to international standards.

    4. Adjudication Method for the Test Set

    Not applicable, as there was no clinical test set requiring adjudication of diagnostic outcomes.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

    No MRMC study was performed or mentioned. This device is a manual ophthalmoscope, not an AI-powered diagnostic device.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    Not applicable. The Vantage Plus Binocular Indirect Ophthalmoscope is a medical instrument used by a human operator, not an algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" here is based on:

    • Physical measurements and engineering specifications: For characteristics like light output, aperture size, lens power, etc.
    • International safety and quality standards: BS EN ISO 15004:1998 (Light Hazard), BS EN ISO 14971:2001 (Risk Management), BS EN 60601-1 and 60601-1-2 (Electrical Safety).
    • Performance of the legally marketed predicate device (Keeler Vantage): The predicate's characteristics serve as the baseline for substantial equivalence.

    8. The Sample Size for the Training Set

    Not applicable. This is not an AI/machine learning device requiring a training set.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, as there is no training set mentioned for this device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K962948
    Manufacturer
    Date Cleared
    1996-10-25

    (88 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Ceralas G is intended to be used as a surgical instrument for photocoagulation of ocular tissue as well as ablation of tissue of the iris and trabeculum. It is already cleared for photocoagulation of retinal tissue.

    Device Description

    The Ceralas G is a complete self-contained compact surgical laser that utilizes a neodymium-doped vttrium aluminum garnet ("Nd:YAG") crystal. The Ceralas G has already been cleared by FDA (K954834) for use as a surgical instrument for photocoagulation of retinal tissue using a hand held fiber optic delivery system. The purpose of this submission is to extend the indications for use of the cleared laser to include photocoagulation of ocular tissue and ablation of tissue of the iris and trabeculum. As explained in this 510(k) notice, the Ceralas G can be attached using an adaptor provided by the Company, without hardware modification, to the Carl Zeiss (K874160 and K925641) or Haag-Streit (K792083) slit lamps, and to the Keeler indirect ophthalmoscopes (K854244 and K942104). No hardware changes have been made to the originally cleared Ceralas G laser. Only certain minor software modifications are required to use the slit lamp as a delivery system. Use of the Ceralas G laser with slit lamps and indirect ophthalmoscopes permits photocoagulation of ocular tissue and ablation of tissue of the iris and trabeculum with the Ceralas G laser. The CeramOptec fiber optic laser delivery system intended for use with the Ceralas G Nd:YAG Laser System has already received clearance from FDA (K935747).

    AI/ML Overview

    1. Acceptance Criteria and Reported Device Performance:

    Acceptance CriteriaReported Device Performance
    Intended Use: Photocoagulation of ocular tissue and ablation of tissue of the iris and trabeculum.The Ceralas G is cleared for these expanded indications for use.
    Compatibility with Delivery Systems: Compatibility with Carl Zeiss and Haag-Streit slit lamps, and Keeler indirect ophthalmoscopes.The Ceralas G can be attached to these slit lamps and indirect ophthalmoscopes using an adaptor, without hardware modification. Minor software modifications are required.
    Similar Treatment Beam Wavelengths: Wavelength of 532 nm (for photocoagulation of ocular tissue). Wavelength within ~3 nm of predicate for ablation of iris/trabeculum.For photocoagulation, the Ceralas G operates at 532 nm, similar to Biovision and Zeiss Lasers. For iris/trabeculum ablation, the Ceralas G operates at 532 nm, which is within 3 nm of the HGM Laser's largest line at 514 nm (within its 488-529 nm range).
    Similar Treatment Beam Power Outputs: Power outputs in ranges comparable to predicate devices.For photocoagulation, Ceralas G provides 0.1 - 3 W, similar to Biovision (0.1 - 3 W), Zeiss (0.1 - 1 W), and Coherent (0.1 - 4 W Argon, 0.05 - 170 W Dye). For iris/trabeculum ablation, Ceralas G provides 0.1 - 3 W, similar to HGM (0.1 - 1 W).
    Similar Pulsed Mode Exposure Duration: Exposure durations in ranges comparable to predicate devices.Ceralas G has a pulsed mode exposure duration of 0.1 - 1 sec. This is comparable to Biovision (0.01 - 3 sec), Zeiss (0.01 - 0.5 sec), Coherent (0.01 - 5 sec), and HGM (0.01 - 0.5 sec).
    Safety and Effectiveness (Clinical Equivalence): No new issues of safety or effectiveness raised by differences in technical characteristics compared to predicate devices.The submission argues that minor differences in wavelength and power do not raise new safety or effectiveness concerns due to: 1) shared delivery systems, 2) close similarity to relevant predicates for specific applications, and 3) user manual instructions for safe power/exposure duration titration.

    2. Sample Size Used for the Test Set and Data Provenance:

    This document does not describe a test set or data provenance in the context of a clinical study or performance evaluation with human subjects or real-world data. The submission focuses on technical equivalence by comparing the Ceralas G's specifications and intended use to existing predicate devices.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

    Not applicable. No ground truth was established by experts for a test set in this submission. The "ground truth" here is the established safety and effectiveness of the existing predicate devices.

    4. Adjudication Method for the Test Set:

    Not applicable. No test set requiring expert adjudication is described.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    Not applicable. This is not an AI/software device and no MRMC study was performed.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    Not applicable. This is a laser device, not an algorithm.

    7. The type of ground truth used:

    The "ground truth" used in this 510(k) submission is the established safety and effectiveness of the identified predicate devices. The argument for substantial equivalence relies on demonstrating that the Ceralas G operates with similar technical characteristics and has the same intended use as these legally marketed devices, and that any differences do not raise new questions of safety or effectiveness.

    8. The Sample Size for the Training Set:

    Not applicable. This document describes a medical device, not a machine learning algorithm. Therefore, there is no "training set."

    9. How the Ground Truth for the Training Set was Established:

    Not applicable. As there is no training set for a machine learning algorithm, there is no ground truth to be established for it.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1